Myopathy-causing mutation R91P in the TPM3 gene drastically impairs structural and functional properties of slow skeletal muscle tropomyosin γβ-heterodimer
Archives of Biochemistry and Biophysics · 2024
DOI: 10.1016/j.abb.2023.109881 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2024. Verfasst von Anastasiia D Gonchar und 10 weiteren Autor:innen. Beteiligte Einrichtung: A.N. Bach Institute of Biochemistry, Research Center of Biotechnology, Russian Academy of Sciences, Moscow, 119071, Russia. Hauptthemen laut MEDLINE: Tropomyosin, Muscular Diseases. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Russian Academy of Sciences, Ministry of Education and Science of the Russian Federation.
Abstract (Originalsprache)
Tropomyosin (Tpm) is a regulatory actin-binding protein involved in Ca2+ activation of contraction of striated muscle. In human slow skeletal muscles, two distinct Tpm isoforms, γ and β, are present. They interact to form three types of dimeric Tpm molecules: γγ-homodimers, γβ-heterodimers, or ββ-homodimers, and a majority of the molecules are present as γβ-Tpm heterodimers. Point mutation R91P within the TPM3 gene encoding γ-Tpm is linked to the condition known as congenital fiber-type disproportion (CFTD), which is characterized by severe muscle weakness. Here, we investigated the influence of the R91P mutation in the γ-chain on the properties of the γβ-Tpm heterodimer. We found that the R91P mutation impairs the functional properties of γβ-Tpm heterodimer more severely than those of earlier studied γγ-Tpm homodimer carrying this mutation in both γ-chains. Since a significant part of Tpm molecules in slow skeletal muscle is present as γβ-heterodimers, our results explain why this mutation leads to muscle weakness in CFTD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- A.N. Bach Institute of Biochemistry, Research Center of Biotechnology, Russian Academy of Sciences, Moscow, 119071, Russia.
- Institute of Mechanics, Moscow State University, Moscow, 119192, Russia.
- Institute of Immunology and Physiology, The Russian Academy of Sciences, Yekaterinburg, 620049, Russia.
- Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- A.N. Bach Institute of Biochemistry, Research Center of Biotechnology, Russian Academy of Sciences, Moscow, 119071, Russia. Electronic address: levitsky@inbi.ras.ru.
Förderung
- Russian Academy of Sciences
- Ministry of Education and Science of the Russian Federation
Zitieren
APA
Gonchar, A. D., Koubassova, N. A., Kopylova, G. V., Kochurova, A. M., Nefedova, V. V., Yampolskaya, D. S., Shchepkin, D. V., Bershitsky, S. Y., Tsaturyan, A. K., Matyushenko, A. M., & Levitsky, D. I. (2024). Myopathy-causing mutation R91P in the TPM3 gene drastically impairs structural and functional properties of slow skeletal muscle tropomyosin γβ-heterodimer. Archives of Biochemistry and Biophysics. https://doi.org/10.1016/j.abb.2023.109881
Vancouver
Gonchar AD, Koubassova NA, Kopylova GV, Kochurova AM, Nefedova VV, Yampolskaya DS, et al. Myopathy-causing mutation R91P in the TPM3 gene drastically impairs structural and functional properties of slow skeletal muscle tropomyosin γβ-heterodimer. Archives of Biochemistry and Biophysics. 2024. doi:10.1016/j.abb.2023.109881
BibTeX
@article{Gonchar2024,
author = {Gonchar, Anastasiia D and Koubassova, Natalia A and Kopylova, Galina V and Kochurova, Anastasia M and Nefedova, Victoria V and Yampolskaya, Daria S and Shchepkin, Daniil V and Bershitsky, Sergey Y and Tsaturyan, Andrey K and Matyushenko, Alexander M and Levitsky, Dmitrii I},
title = {Myopathy-causing mutation R91P in the TPM3 gene drastically impairs structural and functional properties of slow skeletal muscle tropomyosin γβ-heterodimer},
journal = {Archives of Biochemistry and Biophysics},
year = {2024},
doi = {10.1016/j.abb.2023.109881}
}
EUVIMED